Related Experiment Video
Updated: May 4, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
The prognostic value of arterial stiffness in systolic heart failure
Serafettin Demir1, Onur Akpınar, Oguz Akkus
1Department of Cardiology, Adana State Hospital, Adana, Turkey. demirkardiyoloji@hotmail.com.
Insights
Arterial stiffness, measured by augmentation index and pulse wave velocity, significantly predicts mortality in advanced heart failure patients. This simple measurement aids in risk stratification for these individuals.
Area of Science:
- Cardiovascular Medicine
- Clinical Physiology
Background:
- Increased arterial stiffness is a recognized predictor of mortality.
- Advanced heart failure patients often exhibit heightened arterial stiffness.
Purpose of the Study:
- To evaluate the prognostic value of arterial stiffness measurements in predicting mortality in advanced heart failure.
- To assess the relationship between arterial stiffness and mortality over an 18-month follow-up period.
Main Methods:
- Followed 98 patients with advanced heart failure (NYHA class III-IV, LVEF ≤ 35%).
- Measured arterial stiffness using augmentation index (Aix) and pulse wave propagation velocity (PWV) via arteriography.
- Analyzed mortality data over an 18-month period.
Main Results:
- Both Aix and PWV independently predicted mortality (p=0.013, p=0.025).
- Specific cutoff values for Aix (-14.33) and PWV (11.06) demonstrated high sensitivity and specificity for mortality prediction.
- Left ventricular ejection fraction and B-type natriuretic peptide also independently predicted mortality.
Conclusions:
- Arterial stiffness measurement is a valuable, cost-effective tool for mortality prediction in advanced heart failure.
- Aix and PWV provide crucial prognostic information beyond traditional markers.
Background:
Increased arterial stiffness is an indicator of mortality. This study consists of an 18-month follow-up of the mortality in advanced heart failure patients with increased arterial stiffness.
Methods:
The study followed up 98 patients with a diagnosis of heart failure in NYHA class III and IV (76 males, 22 females and mean age of 60 ± 12 years) with a left ventricular ejection fraction ≤ 35% as determined by the Simpson method. Augmentation index (Aix) and pulse wave propagation velocity (PWV) parameters were used as indicators of arterial stiffness. Aix and PWV values were measured by arteriography.
Results:
36 patients died. Both Aix and PWV were powerful determinants of mortality, independent of other prognostic variables (p = 0.013, OR: 0.805; p = 0.025, OR: 0.853). A cutoff value for Aix of -14.33 gave 91.2%, 80.3% sensitivity and specificity. A cutoff value for PWV of 11.06 gave 82.4%, 65.4% sensitivity and specificity mortality was predicted. Left ventricular ejection fraction (p = 0.008, OR: 0.859) and B-type natriuretic peptide (p = 0.01, OR: 0.833) was the other independent determinant of mortality. A significant difference was found in both Aix and PWV between the compensated measurements and decompensated heart failure measurements made in 70 patients (p = 0.035, p = 0.048).
Conclusions:
Measurement of arterial stiffness is a convenient, inexpensive and reliable method for predicting mortality in patients with advanced heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(two-step method)
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Pathophysiology of Heart Failure

